Covid-19 roundup: Man­u­fac­tur­ers strug­gle to keep up with test de­mand; AGC inks deal for Pfiz­er's Omi­cron shot pDNA

In the spring of 2021, de­mand for Covid-19 at-home tests plum­met­ed, and Ab­bott Lab­o­ra­to­ries was forced to dis­card com­po­nents that were ap­proach­ing ex­pi­ra­tion date. Now …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER